Probi Ab Stock Earnings Per Share
| PROB Stock | SEK 350.00 1.00 0.28% |
Probi AB fundamentals help investors to digest information that contributes to Probi AB's financial success or failures. It also enables traders to predict the movement of Probi Stock. The fundamental analysis module provides a way to measure Probi AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Probi AB stock.
Probi |
Probi AB Company Earnings Per Share Analysis
Probi AB's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Probi AB Earnings Per Share | 6.26 X |
Most of Probi AB's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Probi AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Probi AB has an Earnings Per Share of 6.26 times. This is 25.21% lower than that of the Biotechnology sector and 230.69% lower than that of the Health Care industry. The earnings per share for all Sweden stocks is 100.64% lower than that of the firm.
Probi Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Probi AB's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Probi AB could also be used in its relative valuation, which is a method of valuing Probi AB by comparing valuation metrics of similar companies.Probi AB is currently under evaluation in earnings per share category among its peers.
Probi Fundamentals
| Return On Equity | 0.0304 | |||
| Return On Asset | 0.0211 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.15 B | |||
| Shares Outstanding | 11.39 M | |||
| Shares Owned By Insiders | 68.60 % | |||
| Shares Owned By Institutions | 23.77 % | |||
| Price To Earning | 37.39 X | |||
| Price To Book | 1.61 X | |||
| Price To Sales | 3.60 X | |||
| Revenue | 658.18 M | |||
| Gross Profit | 255.44 M | |||
| EBITDA | 182.49 M | |||
| Net Income | 83.14 M | |||
| Cash And Equivalents | 251.02 M | |||
| Cash Per Share | 12.70 X | |||
| Total Debt | 62.73 M | |||
| Debt To Equity | 1.80 % | |||
| Current Ratio | 3.54 X | |||
| Book Value Per Share | 123.80 X | |||
| Cash Flow From Operations | 154.19 M | |||
| Earnings Per Share | 6.26 X | |||
| Target Price | 317.8 | |||
| Number Of Employees | 154 | |||
| Beta | 0.51 | |||
| Market Capitalization | 2.08 B | |||
| Total Asset | 1.43 B | |||
| Retained Earnings | 103 M | |||
| Working Capital | 161 M | |||
| Current Asset | 202 M | |||
| Current Liabilities | 41 M | |||
| Z Score | 19.8 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 0.83 % | |||
| Net Asset | 1.43 B | |||
| Last Dividend Paid | 1.3 |
About Probi AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Probi AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Probi AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Probi AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Probi Stock Analysis
When running Probi AB's price analysis, check to measure Probi AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Probi AB is operating at the current time. Most of Probi AB's value examination focuses on studying past and present price action to predict the probability of Probi AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Probi AB's price. Additionally, you may evaluate how the addition of Probi AB to your portfolios can decrease your overall portfolio volatility.